$Taiwan Semiconductor(TSM.US)

Even as semicon sector takes a beating, chips is still doing relatively ok. This tells you there is still healthy confidence in chips related stocks. Anything between earnings calls are all noise. Stay vested!

$Corning(GLW.US)

Context: When I invest in optical infrastructure leaders like Corning, I deliberately adopt a patient mindset to allow complex business transformations to mature. Connecting modern GPU compute clusters requires massive amounts of high density optical fiber, and I am committed to holding through low volatility basing periods while this secular connectivity demand compounds.

My trade: I am maintaining my core long position without making any adjustments today. My average cost basis is established at 157.5, and with strict asset allocation and risk budgeting already in place, I feel completely comfortable giving this multiyear optical expansion theme the necessary time to compound.

Takeaway: Enduring slow consolidation phases in mission critical hardware suppliers is the price of admission for long term alpha.

$Comfort Systems USA(FIX.US)

Context: I really like its moat in complex data center liquid cooling, where high technical difficulty keeps competitors out. After a huge run, the stock is just resting in consolidation, but ongoing data center buildouts remain a solid long term business Catalyst.

My trade: I am patiently waiting on the sidelines. If the price drops to 1500 dollars or below, I will start dollar cost averaging in for a better margin of safety.

Takeaway: Strong technical barriers create a durable moat, but at current valuation levels, do you expect another leg up or a deeper pullback?

$Microsoft(MSFT.US)

Context: MSFT has gained about 29% since February, recovering strongly from around US$352 and recently reaching above US$500. The move reflects renewed confidence in its AI and cloud businesses.

My trade: I bought during the earlier weakness and have held through the recovery. I’m not looking to chase the recent surge but I’m also not rushing to take profits.

Takeaway: MSFT is another one of my wide-moat holdings so I’m comfortable holding it longer term. The big question is whether its huge AI capex spending will generate enough revenue and cash flow to justify the investment. Azure is growing strongly but the payoff needs to keep catching up with the spending.

$Alphabet(GOOGL.US)

Context:

Alphabet (GOOGL) is around 345. The recent pullback is mainly about concerns over huge AI infrastructure spending and rising capex, rather than a deterioration in the core business. At the same time, Q2 was very strong: revenue grew 24%, Search grew 17%, YouTube Ads 13%, and Google Cloud jumped 82%, with Cloud backlog reaching $514B.

Analysts remain broadly bullish. The current 12-month consensus target is around 428, with a range of roughly 340-515. Recent targets include $410 from Rosenblatt, $425 from Barclays, $440 from Roth and $465 from BMO.

My trade:

Currently about my cost price.

Since the position is already around breakeven, I would hold. I would only add aggressively if GOOGL falls toward 325. Above $380, I would stop chasing and let the position run.

Takeaway:

Hold. I like GOOGL here for a medium/long-term position. The AI capex is the main risk, but the underlying business is still accelerating—especially Cloud and AI monetisation.

I would treat 400 as the first meaningful profit taking checkpoint and 425-450 as the area where I'd consider selling 20-30%, rather than selling everything.

$Oracle(ORCL.US)

Oracle: AI Goldmine or Cash-Flow Trap?

Project Jupiter puts Oracle firmly in the AI infrastructure race, but the price of that ambition is heavy. FY2026 revenue rose 17% to US$67.4bn, yet free cash flow swung to -US$23.7bn as capex ballooned to US$55.7bn.

The bull case remains compelling: Oracle’s backlog reached US$638bn, while management expects FY2027 revenue of about US$90bn. But Jupiter’s power-pipeline delay highlights the key risks—execution, financing, construction costs and when these investments actually translate into cash.

Analysts remain broadly positive, though targets vary sharply, reflecting concerns over valuation and capital intensity.

View: HOLD, not chase. Meaningful accumulation would be closer to US$135–145, where risk/reward improves.

For option writers, I prefer a bullish cash-secured put over buying calls: 30–60 DTE, around 0.20–0.30 delta, targeting US$125–135 strikes. If assigned, covered calls around US$165–180 could monetise the rebound.

The AI opportunity is real—but Jupiter has to turn billions of capex into billions of cash flow.

Not financial advice.

$NU Holdings(NU.US)Profit Growth & Long Term Potential

🌎 NU continues to stand out as one of the more interesting digital banking growth stories, with the business increasingly shifting from customer acquisition toward scalable profitability.

📈 Q2 revenue reached $5.88B, up 39% YoY, while net income rose 49% to $1.06B. Customers reached 138.9M, the credit portfolio grew 37% to $39.4B, and ROE reached 33%. The $1B share buyback adds another potential catalyst.

🔎 Customer growth, NII and credit growth, sustainable margins, Mexico expansion, U.S. banking opportunities and credit quality.The main risk remains credit quality as lending expands and 90+ day NPLs rise.

🎯 NU is increasingly looking like a profitable digital bank rather than simply a high growth fintech. Long term bias remains Bullish with $15 the key level to watch.

$Amazon(AMZN.US)Context: Amazon is turning its long-delayed drone-delivery dream into a much larger business. The company plans to expand Prime Air to nearly 500 U.S. cities and towns by the end of 2026, a sixfold increase from its current footprint. The Prime Air expansion is strategically important, even if it does not immediately move Amazon's earnings. Amazon currently operates Prime Air from 11 locations and plans to reach nearly 500 cities and towns by year-end. The drones can carry packages weighing up to five pounds, with eligible orders arriving in as little as 30 minutes. Amazon says it has already completed hundreds of thousands of drone deliveries this year and expects roughly 1 million deliveries in 2026.

My Trade: I am still holding on to my position bought earlier during the dips last year. I am currently targeting a $230-$240 range before I add more.

Takeaway: Prime Air could make Amazon more valuable. Faster delivery can encourage customers to order more frequently, particularly groceries, medicines, and everyday essentials. With Amazon competing with other rivals like Walmart, this innovation, if scaled appropriately and efficiently, can take them to the next level in the transportation.

@Captain's Treasure

CONTEXT

Amazon.com Inc ($Amazon(AMZN.US)) trades at $261.43, showcasing immense operational momentum. In its recent Q2 earnings blockbuster, total revenue surged 20% year-over-year to $200.6 billion, crushing Wall Street estimates.The clear star of the show was Amazon Web Services (AWS), which re-accelerated to a spectacular 37% YoY growth rate, reaching $42.2 billion. AWS now boasts a $496 billion remaining contract backlog and generates over 60% of Amazon’s total operating income ($16.6B) at a massive 39.4% operating margin. Simultaneously, high-margin advertising revenue jumped 26% to $19.8 billion.While management aggressively scaled up 2026 cash CapEx to a projected $220 billion for AI server infrastructure, pushing trailing 12-month free cash flow into a brief $7.6 billion deficit, the market rewarded the spend. CEO Andy Jassy highlighted the rapid, predictable payback period on these servers, with 2027 and 2028 customer compute capacity already heavily reserved.

MY TRADE

I am executing a structured Long Position on $Amazon(AMZN.US), setting a primary technical price target of $315 over the next 6 to 12 months, tracking current institutional fair-value models. Rather than chasing the post-earnings spike, I am setting limit orders to build exposure in tiers during short-term macroeconomic pullbacks. This positioning captures the explosive, triple-digit growth across Amazon’s custom AI chips (Trainium) and core cloud ecosystem.

TAKEAWAY

Amazon is successfully transitioning from a low-margin e-commerce giant into a highly profitable AI and enterprise cloud powerhouse. The market no longer fears heavy CapEx because Amazon’s cash generation from operations remains an absolute fortress at $161.4 billion. Short-term cash flow contractions are an intentional trade-off to lock in long-term cloud dominance.

$Keppel(BN4.SG)

Context: Keppel at S$11.35 remains technically constructive, with the 50MA at S$11.12 above the 200MA at S$10.90, keeping the golden cross intact.

My trade: Holding my position and watching whether the 20MA at S$11.26 continues to provide support.

Takeaway: I expect the broader trend to remain upward, with the technical setup supporting my view on Keppel.

$Invesco QQQ Trust(QQQ.US)$Invesco Nasdaq 100 ETF(QQQM.US)As we mentioned last week, the market is finally starting to broaden. Even though QQQ looked relatively weak, underlying breadth has improved noticeably, with more sectors participating instead of just the usual AI leaders.

The biggest surprise was the rebound in liquidity-sensitive names. Following Bessent’s Treasury bond-buying move, capital quickly rotated back into higher-beta assets, suggesting investors are becoming more comfortable taking risk again.

That doesn’t mean the index is out of consolidation, but it does show a healthier market beneath the surface. If breadth keeps expanding, this rotation could become more important than QQQ’s headline performance alone.

@Captain's Treasure

NVIDIA: More Than Just a Chip Company 🚀

NVIDIA has become one of the most important companies in the AI revolution.

What started with GPUs for gaming has evolved into a full-stack AI ecosystem spanning chips, networking, software, data centers, and increasingly robotics.

The interesting part isn’t just how powerful its GPUs are—it’s the ecosystem NVIDIA has built around them.

AI infrastructure is becoming a foundational layer of the digital economy, and NVIDIA is sitting right at the center of that shift.

The big question for investors isn’t whether AI will matter. It’s how much of that future is already reflected in NVIDIA’s valuation.

One thing is clear: the AI race is far from over.

#NVIDIA #NVDA #AI #ArtificialIntelligence #Semiconductors #Tech #Investing$NVIDIA(NVDA.US)

$NVIDIA(NVDA.US)

Still holding NVIDIA and letting the investment play out. AI is still in the early stages, and I believe the demand for computing power will remain strong for years. There will definitely be volatility along the way, but I’m comfortable holding through the ups and downs for the bigger picture.

$Defi Tech(DEFT.US)finally the time have come to this stock. Bitcoin have gone up, so does this. Hope will rise above 1. Let pray

$Palantir Tech(PLTR.US)Palantir stock has jumped about 46% in August and 43% since its August 3 earnings report. Still, Wall Street sees about 10% upside from current levels. Trump's investment accounts also bought Palantir shares in June, adding another point of interest as the stock continues to rally. However, the stock's high valuation could limit further gains if growth slows.The company's revenue jumped 93% year over year, while U.S. commercial revenue rose 149% to $764 million. Earnings per share came in at $0.41, which beat the consensus estimate of $0.35 per share. Operating cash flow also reached $1.22 billion. The results showed continued strong demand for Palantir's products across commercial and government customers. Following Palantir's Q2 results, analysts upgraded the target price for Palantir, with an average of $200.

Personally, I took partial profit at around the $160 mark. Despite overall optimism on the company, I also held through the lows when it struggled to even break through $130 for the 1st half of the year. Hence, I will continue to hold and only look to buy more when the stock pulls back to $140+ or sell when the stock reaches $210+. @Captain's Treasure

$NVIDIA(NVDA.US)

Nvidia’s earnings report this Wednesday has everyone on edge. Even with news circulating today about Nvidia GPUs hiking prices by 15%, I’m genuinely anxious. I actually cut losses last week instead of taking profits—that’s how worried I am!

I’m staying completely hands-off with the AI sector this week, and I‘ll likely just wait and see next week.

As for Friday’s Fed meeting minutes, will they soften their hawkish tone? Their tactics might shift, but changing their core hawkish posture is tough.

Sitting on the sidelines feels much safer right now. What’s your move?

$Genting Sing(G13.SG)

Context: The tourism and hospitality sector in Singapore continues to exhibit strong baseline demand, supporting Resorts World Sentosa’s steady operational recovery.

My trade: Holding 5,000 shares of Genting Sing (G13) at an average cost of 0.610 SGD, capturing a solid +6.55% profit margin as a fundamental growth anchor.

Takeaway: Next time, I will systematically sell covered call options against long positions during local consolidation phases to harvest extra option premium.

$BABA-W(09988.HK)

I know that any Alibaba retail holders are worried about Alibaba’s HKD80 billion share placement news..… and today’s sharp -8.70% drop to HKD112.30 makes it even harder to stomach.

My current cost is HKD113.27, slight below my average price. I am not worry much as I look at the bigger picture for this company. I may look into buying more Alibaba if it goes lower.

Since May 2022, my cumulative P/L is still +HKD12,261.87.

Yes, the placement news spooked the market and the sentiment is shaky. But this is short-term noise against solid long-term fundamentals. Alibaba is not an ordinary company.

I am not panicking .I am staying the course. The market overreacts and conviction pays off.

Hold tight, BABA dragon 🐉💪

$Moderna(MRNA.US)

1️⃣ Exploded high after Moderna and Merck announced positive Ph3 result for their personalised mRNA melanoma cancer therapy, the first mRNA cancer treatment to achieve such a milestone. The news triggered a major short squeeze and a sharp re rating of Moderna’s future prospects.

2️⃣ I added a position cause the market narrative changed from a declining COVID company to a potential cancer treatment platform. One successful Ph3 trial can reshape future revenues expectations.

3️⃣ AI stocks depend mainly on earnings, adoption and valuation. MRNA depends on clinical, regulatory and pipeline milestones. In 2 months, I would gauge MRNA by follow through data and institutional support, not hype. 💊🩻🩺

$NIO Inc(NIO.US) The post-Q1 sell-off in NIO increasingly looks like a buy-the-dip setup. Since its Q1 earnings report in May 2026, the Shanghai-based electric vehicle (EV) maker's ADR has fallen from about $5.59 to $4.53, down nearly 19%. Yet Q1 itself was not the problem. The initial reaction was positive, with revenue beating expectations, vehicle margin reaching 18.8% vs. 10.2% a year ago, and adjusted operating profit near breakeven. A key focus of the upcoming earnings report will be whether the company can post non-GAAP profitability for a third consecutive quarter. Nio recorded adjusted operating profit of 66.8 million yuan in the first quarter, while revenue surged 112.2% year-on-year to 25.53 billion yuan. Its overall gross margin expanded to 19.0%, the highest in 4 years. However, second-quarter deliveries were somewhat weaker than expected. Nio delivered 107,658 vehicles during the quarter, below the lower end of its guidance range of 110,000 to 115,000 units. Even so, the figure represented a 49.4% increase year-on-year. Nio had previously guided for second-quarter revenue of between 32.78 billion yuan and 34.44 billion yuan. Investors will also be watching management's guidance for third-quarter deliveries and revenue, as well as its comments on the full-year profitability target. And I have been buying the dips, though more dips came after each one. I believe in the management that if strategies work well, they can continue to raise profit margins. I'm holding back for now to see the earnings next week. @Captain's Treasure

$Amova-StraitsTrdg Asia REIT(CFA.SG)paid a distribution of S$0.011 per unit on 3 August 2026, following its 1 July ex-dividend date and 2 July record date. SGX subsequently published the tax-treatment breakdown, including a taxable-income component of S$0.008703 per unit.Based on the latest trailing distribution data, CFA's trailing dividend yield is around 6.3%, with distributions paid quarterly.

However, I would not assume the 6%+ yield is guaranteed going forward because CFA's distributions depend on the income generated by its underlying REIT holdings.

The ETF's recent market price was around S$0.796, while its 52-week range was approximately S$0.76–S$0.826.

So CFA is currently trading near the lower end of its 52-week range, which may be interesting for investors focused on income.

In short, I would describe CFA as more attractive for income investors than growth investors,, particularly if you believe Asian REITs will benefit from a more favourable interest-rate environment.But I would not buy CFA solely because the yield looks high. I would also look at interest-rate direction, underlying REIT DPU growth, gearing/refinancing costs and whether the ETF's NAV continues to recover.CFA's main advantage is diversification, while individual REITs can offer more targeted exposure and potentially higher upside.

$NVIDIA(NVDA.US)

Expect this to go back to its recent highs after earnings. Jensen has been quietly making deals behind the scenes. Not the circular financing kind that we already know. There are many ticker choices now but only one with the cashflow of a king!

Context: TMO has been on a strong run, gaining about 34% since April and recently reaching around US$629. The steady climb reflects confidence in its healthcare and life sciences businesses.

$Thermo Fisher Scentific(TMO.US)

My trade: I bought TMO around the April lows and have held through the recovery. I have not taken profits yet, as I consider TMO a stronger-moat stock that I’m more comfortable holding for longer.

Takeaway: TMO benefits from its scale, broad product range and strong position in life sciences. Will continue holding while watching valuation and any slowdown in research and healthcare spending.

$Tencent 5xLongSG270930(PSJW.SG)$Tencent

Context: Tencent has been a painful one for me. My 5x Long position went quite deep into red before, and I DCA several times to bring my average down. It has recovered from the recent low, but I’m still at -13.33% with market price 0.039 vs my average 0.045.

My trade: I’m still holding because I think Tencent has room to recover, but with 5x leverage the movement is really unforgiving. Even when the underlying rebounds, recovering the DLC loss is not always as fast as I expected.

Takeaway: DCA on a leveraged product needs much more patience and risk control. Next time I would probably enter smaller first instead of averaging down too aggressively. @Captain's Treasure